Myocardial regeneration strategy using wharton's jelly multipotent stem cells as an 'unlimited' therapeutic agent: 3-year outcomes in a pilot cohort of circulate-acute myocardial infarction trial.
27 August 2018 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker

John Paul II Hospital, Krakow (Poland)
9 More presentations in this session
Access the full session
The Event
ESC Congress 2018
27 August 2018
08:30 CET
